scholarly journals The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma

2018 ◽  
Vol 9 ◽  
Author(s):  
Kim A. T. Verheijden ◽  
Saskia Braber ◽  
Thea Leusink-Muis ◽  
Prescilla V. Jeurink ◽  
Suzan Thijssen ◽  
...  
Keyword(s):  
Mast Cell ◽  
Combination Therapy ◽  
House Dust ◽  
House Dust Mite ◽  
Murine Model ◽  
Mast Cell Degranulation ◽  
Dust Mite

scholarly journals Mast cell‐derived serotonin enhances methacholine‐induced airway hyperresponsiveness in house dust mite‐induced experimental asthma

Allergy ◽  
2021 ◽  
Author(s):  
Erika Mendez‐Enriquez ◽  
Perla Abigail Alvarado‐Vazquez ◽  
Willem Abma ◽  
Oscar E. Simonson ◽  
Sergey Rodin ◽  
...  
Keyword(s):  
Mast Cell ◽  
House Dust ◽  
House Dust Mite ◽  
Airway Hyperresponsiveness ◽  
Dust Mite

scholarly journals Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthma

2018 ◽  
Vol 14 (1) ◽  
Author(s):  
Yao-Tung Wang ◽  
Hsu-Chung Liu ◽  
Hui-Chen Chen ◽  
Yen-Ching Lee ◽  
Tung-Chou Tsai ◽  
...  
Keyword(s):  
Allergic Asthma ◽  
House Dust ◽  
House Dust Mite ◽  
Murine Model ◽  
Oral Immunotherapy ◽  
Mite Extract ◽  
Dust Mite ◽  
House Dust Mite Extract

scholarly journals Prophylactic benefits of systemically delivered simvastatin treatment in a house dust mite challenged murine model of allergic asthma

2018 ◽  
Vol 175 (7) ◽  
pp. 1004-1016 ◽  
Author(s):  
Aruni Jha ◽  
Min H Ryu ◽  
Ojo OO ◽  
Hilary J Bews ◽  
Jules C Carlson ◽  
...  
Keyword(s):  
Allergic Asthma ◽  
House Dust ◽  
House Dust Mite ◽  
Murine Model ◽  
Simvastatin Treatment ◽  
Dust Mite

Mast cell-derived serotonin enhances methacholine-induced airway hyperresponsiveness in house dust mite-induced experimental asthma

2021 ◽  
Author(s):  
Erika Haide Mendez ◽  
Perla Abigail Alvarado Vazquez ◽  
Willem Abma ◽  
Oscar Simonson ◽  
Sergey Rodin ◽  
...  
Keyword(s):  
Mast Cell ◽  
House Dust ◽  
House Dust Mite ◽  
Airway Hyperresponsiveness ◽  
Dust Mite

scholarly journals Mast Cell-Deficient KitW-shMice Develop House Dust Mite-Induced Lung Inflammation despite Impaired Eosinophil Recruitment

2014 ◽  
Vol 6 (2) ◽  
pp. 219-226 ◽  
Author(s):  
J. Daan de Boer ◽  
Jack Yang ◽  
Florry E. van den Boogaard ◽  
Arie J. Hoogendijk ◽  
Regina de Beer ◽  
...  
Keyword(s):  
Mast Cell ◽  
House Dust ◽  
House Dust Mite ◽  
Lung Inflammation ◽  
Eosinophil Recruitment ◽  
Dust Mite

The Role of Chitin and TNF-Alpha in Airway Inflammation Induced By House Dust Mite in Murine Model

2014 ◽  
Vol 133 (2) ◽  
pp. AB400
Author(s):  
Sang Min Lee ◽  
Joon Pyo Choi ◽  
Young Min Kim ◽  
Seung Jin Choi ◽  
Hyun Taek Park ◽  
...  
Keyword(s):  
Airway Inflammation ◽  
House Dust ◽  
House Dust Mite ◽  
Murine Model ◽  
Tnf Alpha ◽  
Dust Mite

scholarly journals Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series

2021 ◽  
pp. 469-472
Author(s):  
P C Kathuria ◽  
Manisha Rai
Keyword(s):  
Combination Therapy ◽  
Disease Control ◽  
House Dust ◽  
House Dust Mite ◽  
Immunoglobulin E ◽  
Combined Therapy ◽  
Case Series ◽  
Chronic Spontaneous Urticaria ◽  
Dust Mite ◽  
Urticaria Activity Score

Chronic spontaneous urticaria (CSU) is a heterogeneous disorder with recurrent pruritic wheals and/or angioedema. The anti-immunoglobulin E (omalizumab) is used in CSU patients resistant to four-fold second-generation anti-histamines. Most clinical trials have experienced relapse after stopping omalizumab treatment. Here, we present a case series of five cases of chronic atopic urticarial concomitant allergic rhinitis and asthma which have shown immunologically significant positivity to Dermatophagoides pteronyssinus and Dermatophagoides farinae. Disease control was achieved (Urticaria Activity Score 7 <6) in four cases by combination therapy of omalizumab with house dust mite (HDM) Allergen Immunotherapy (AIT) and remained sustained for three years on follow-up even after discontinuation of AIT for one year. We hypothesize that this combined therapy may contribute to enhanced clinical efficacy, safety, and faster achievement of disease control in CSU.

Sign in / Sign up

Export Citation Format

Share Document